About 2,180 results
Open links in new tab
FDA Approves First Subcutaneous Infliximab Product - Center for …
Kashiv, Amneal Receive First FDA Approval for Their Filgrastim …
Center for Biosimilars®
FDA Approves Amgen's Trastuzumab Biosimilar, Kanjinti
Eli Lilly Launching Lower-Priced Authorized Generic of Its Insulin …
Despite Steep Discounts, Humira Biosimilars Are Priced More Than ...
Real-world Study of Reference vs Biosimilar Ranibizumab for …
FDA Approves Semglee Insulin Glargine as First Interchangeable …
FDA Releases Final Guidance on Immunogenicity Testing for …
ACMA Begins Board Certification Program for Biologics, …